Skip to main content

Table 3 Patient treatments and outcomes

From: The ICU-venous thromboembolism score and tumor grade can predict inhospital venous thromboembolism occurrence in critical patients with tumors

Characteristics

With VTE

N = 312

Without VTE

N = 248

P

Treatments

 CVC, N (%)

293 (93.9)

230 (92.7)

0.580

 Invasive mechanical ventilation, N (%)

307 (98.4)

244 (98.4)

0.992

 Transfusion of blood component, N (%)

175 (56.1)

122 (49.2)

0104

  RBC transfusion, N (%)

135 (43.3)

95 (38.3)

0.239

  Platelet transfusion, N (%)

30 (9.6)

31 (12.5)

0276

  Fresh frozen plasma transfusion, N (%)

162 (51.9)

105 (42.3)

0.024

 TPN, N (%)

213 (68.3)

162 (65.3)

0.461

 Pharmacologic prophylaxis, N (%)

179 (57.4)

176 (71.0)

0.001

Outcomes

 

 Lowest Hb level in hospital, g/dL, IQR

79.5 (69.0–95.0)

82.0 (70.8–101.0)

0.029

 Duration of mechanical ventilation, d, range

1 (1–17)

1 (1–8)

0.015

 ICU length of stay, d, IQR

4 (2–8)

3 (1–6)

< 0.001

 Immobilization duration, d, IQR

4 (2–8)

3 (1–5)

< 0.001

 Immobilization ≥ 4 days, N (%)

195 (62.5)

89 (35.9)

< 0.001

 Hospital length of stay, d, IQR

23.5 (15–36.8)

19 (14–30)

0.005

The ICU-VTE score, IQR

11.0 (9.0–12.0)

9.0 (7.0–11.0)

< 0.001

 Low risk, 0–8 points, N (%)

44 (14.1)

87 (35.1)

< 0.001

 Intermediate risk, 9–14 points, N (%)

251 (80.4)

161 (64.9)

 

 High risk, 15–18 points, N (%)

17 (5.4)

0

 
  1. Data are N (% of total available data within each column), mean ± SD, or median (IQR)